Canine immune-mediated thrombocytopenia

Susan Holt
Sunday, June 2, 2019

Immune-mediated thrombocytopenia (IMT) is a common disease in dogs. Primary IMT is idiopathic, while secondary IMT can result from a variety of infectious agents or some treatments. Symptoms may include lethargy, anorexia and mild pyrexia, together with a low platelet count and associated bleeding disorders. Prognosis is generally positive, but reduced with presence of melena or raised blood urea nitrogen. Treatment will include some form of immunosuppressive therapy, such as prednisolone, which can have multiple side effects. Nursing the IMT patient will aim at monitoring and reducing spontaneous haemorrhage and managing treatment side effects. To ensure owner understanding and compliance, it is vital to discuss these side effects and any appropriate home adjustments so an achievable plan can be developed for home care.

Subscribe to get full access to The Veterinary Nurse

Thank you for vising The Veterinary nurse and reading our archive of expert clinical content. If you would like to read more from the leading peer-reviewed journal for veterinary nurses, you can start your subscription today for just £26.

Subscribing will enable you to:

  • Stay up-to-date with current thinking and best practice in veterinary medicine
  • Enhance your knowledge and understanding of all key clinical topics
  • Achieve the mandatory requirement of 45 hours' documented CPD over a three-year period
Subscribe now

Already registered? - Sign in here

Download Now

Keep up to date with The Veterinary Nurse!

Sign up to The Veterinary Nurse's regular newsletters and keep up-to-date with the very latest clinical research and CPD we publish each month.